{"id":"d-z","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL1601","moleculeType":"Small molecule","molecularWeight":"542.58"},"_dailymed":{"setId":"f9f15374-4809-4b96-8a07-3c2f1011d110","title":"M-NATAL PLUS (VITAMIN A, VITAMIN C, VITAMIN D, VITAMIN E, THIAMINE, RIBOFLAVIN, NIACIN, VITAMIN B6, FOLIC ACID, VITAMIN B12, CALCIUM, IRON, ZINC, COPPER) TABLET [BRYANT RANCH PREPACK]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Daclatasvir is an NS5A inhibitor that disrupts hepatitis C virus replication and assembly, while sofosbuvir is a nucleotide analog NS5B polymerase inhibitor that terminates viral RNA chain elongation. Together, they provide a direct-acting antiviral combination effective against multiple HCV genotypes without requiring ribavirin or interferon.","oneSentence":"D+Z is a fixed-dose combination of daclatasvir and sofosbuvir that inhibits hepatitis C virus NS5A and NS5B proteins to block viral replication.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:08:23.000Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic hepatitis C virus infection (genotype-independent)"}]},"trialDetails":[{"nctId":"NCT02311933","phase":"PHASE2","title":"Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-05-28","conditions":"Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7","enrollment":81},{"nctId":"NCT02180867","phase":"PHASE2, PHASE3","title":"Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-07-11","conditions":"Alveolar Soft Part Sarcoma, Angiomatoid Fibrous Histiocytoma, Atypical Fibroxanthoma","enrollment":140},{"nctId":"NCT03418038","phase":"PHASE2","title":"Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-03-23","conditions":"Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent Diffuse Large B-Cell Lymphoma","enrollment":80},{"nctId":"NCT03178552","phase":"PHASE2, PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2017-09-22","conditions":"Non-Small Cell Lung Cancer","enrollment":1000},{"nctId":"NCT06647953","phase":"PHASE3","title":"Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2025-03-21","conditions":"Pleuropulmonary Blastoma","enrollment":110},{"nctId":"NCT03007147","phase":"PHASE3","title":"Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2017-08-08","conditions":"Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia","enrollment":475},{"nctId":"NCT04199026","phase":"NA","title":"Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2025-02-25","conditions":"Metastatic Sarcoma, Recurrent Sarcoma, Resectable Sarcoma","enrollment":20},{"nctId":"NCT06820957","phase":"PHASE2, PHASE3","title":"Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2025-11-10","conditions":"CIC-Rearranged Sarcoma, Metastatic Ewing Sarcoma, Metastatic High Grade Sarcoma","enrollment":437},{"nctId":"NCT07382882","phase":"NA","title":"The Effect of Orally Administered Extracts of Chokeberry, Kamchatka Berry and Blueberry on the Condition of the Eye.","status":"COMPLETED","sponsor":"Wroclaw Medical University","startDate":"2022-11-03","conditions":"Presbyopia","enrollment":27},{"nctId":"NCT04255615","phase":"NA","title":"Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF Outcomes","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2020-02-12","conditions":"Infertility, in Vitro Fertilization (IVF), ART","enrollment":4000},{"nctId":"NCT05414903","phase":"NA","title":"Reading Outcomes in Children With Vestibular Loss","status":"RECRUITING","sponsor":"Father Flanagan's Boys' Home","startDate":"2022-06-06","conditions":"Vestibular Disorder, Hearing Loss, Sensorineural","enrollment":90},{"nctId":"NCT02112916","phase":"PHASE3","title":"Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-10-04","conditions":"Adult T Acute Lymphoblastic Leukemia, Ann Arbor Stage II Adult Lymphoblastic Lymphoma, Ann Arbor Stage II Childhood Lymphoblastic Lymphoma","enrollment":847},{"nctId":"NCT05662033","phase":"PHASE1","title":"A Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oral AZD6793 in Healthy and Chronic Obstructive Pulmonary Disease Participants, to Assess the Relative Oral Bioavailability Between Two Formulations, and the Food Effect on the PK of AZD6793 Compared to Fasting State.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2022-12-05","conditions":"Inflammatory Diseases","enrollment":93},{"nctId":"NCT06114628","phase":"PHASE2","title":"Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB","status":"RECRUITING","sponsor":"University College, London","startDate":"2024-01-09","conditions":"Pulmonary Tuberculosis","enrollment":2500},{"nctId":"NCT06905509","phase":"PHASE2","title":"Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma","status":"RECRUITING","sponsor":"Joseph Tuscano","startDate":"2025-07-31","conditions":"Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements","enrollment":25},{"nctId":"NCT05766267","phase":"PHASE2, PHASE3","title":"Short-course Regimens for the Treatment of Pulmonary Tuberculosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centers for Disease Control and Prevention","startDate":"2023-11-21","conditions":"Tuberculosis, Pulmonary, Tuberculosis Infection","enrollment":288},{"nctId":"NCT07163143","phase":"PHASE3","title":"Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)","status":"NOT_YET_RECRUITING","sponsor":"University College, London","startDate":"2025-11","conditions":"Tuberculosis (TB)","enrollment":784},{"nctId":"NCT07149974","phase":"NA","title":"Neurofeedback Training for Autistic Children","status":"ENROLLING_BY_INVITATION","sponsor":"Education University of Hong Kong","startDate":"2025-07-01","conditions":"Autism, Autistic Disorders Spectrum, Neurofeedback","enrollment":30},{"nctId":"NCT07020325","phase":"NA","title":"Comparative Analysis of Bipolar Enucleation of the Prostate Using Different Commercial Types of Electrodes","status":"NOT_YET_RECRUITING","sponsor":"Menoufia University","startDate":"2025-07-01","conditions":"Bipolar Enucleation of the Prostate","enrollment":100},{"nctId":"NCT04844424","phase":"PHASE1","title":"A Study of JNJ-70033093 (Milvexian) in Healthy Adult Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-04-14","conditions":"Healthy","enrollment":115},{"nctId":"NCT05038644","phase":"PHASE1","title":"XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia","status":"TERMINATED","sponsor":"Ehab L Atallah","startDate":"2022-02-02","conditions":"Acute Myeloid Leukemia, T Cell Acute Lymphoblastic Leukemia, T Cell Lymphoblastic Lymphoma","enrollment":22},{"nctId":"NCT05106153","phase":"PHASE1","title":"A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and Zolpidem","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-12-17","conditions":"Healthy Non-dependent, Recreational Sedative Users, Abuse Potential","enrollment":127},{"nctId":"NCT00614666","phase":"PHASE1, PHASE2","title":"Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment","status":"TERMINATED","sponsor":"University of Arizona","startDate":"2007-09","conditions":"Coccidioidomycosis","enrollment":6},{"nctId":"NCT03509285","phase":"PHASE1","title":"A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users","status":"COMPLETED","sponsor":"SK Life Science, Inc.","startDate":"2017-03-08","conditions":"Healthy Volunteer","enrollment":53},{"nctId":"NCT05727852","phase":"","title":"Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases","status":"ENROLLING_BY_INVITATION","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2023-01-30","conditions":"Chronic Respiratory Diseases, Cystic Fibrosis, Lymphangioleiomyomatosis","enrollment":400},{"nctId":"NCT01979536","phase":"PHASE2","title":"Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2013-11-13","conditions":"Anaplastic Large Cell Lymphoma, ALK-Positive, Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma, Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma","enrollment":137},{"nctId":"NCT04145258","phase":"PHASE3","title":"Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis","status":"RECRUITING","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2021-02-07","conditions":"Tuberculous Meningitis","enrollment":768},{"nctId":"NCT05248516","phase":"PHASE2, PHASE3","title":"ComPAS Low-WAZ RCT Mali","status":"UNKNOWN","sponsor":"International Rescue Committee","startDate":"2022-09-01","conditions":"Acute Malnutrition in Infancy, Acute Malnutrition in Childhood, Underweight","enrollment":1500},{"nctId":"NCT06084442","phase":"NA","title":"Evaluation of The Techniques in Correcting Large-Angle Exotropia","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2023-10","conditions":"Exotropia, Evaluation of Surgical Techniques in Correcting Exotropia","enrollment":50},{"nctId":"NCT06005870","phase":"PHASE2","title":"Zanubrutinib Combined With R-CHOP in the Treatment of Newly Diagnosed DLBCL With p53 Protein Expression","status":"RECRUITING","sponsor":"Huazhong University of Science and Technology","startDate":"2022-11-26","conditions":"Diffuse Large B Cell Lymphoma","enrollment":41},{"nctId":"NCT04604795","phase":"PHASE1","title":"Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to Evaluate the Interaction Between GSK3915393 and Grapefruit Juice and Itraconazole","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2020-11-04","conditions":"Celiac Disease, Coeliac Disease","enrollment":65},{"nctId":"NCT05629624","phase":"NA","title":"Evaluation of Executive Function and Emotional Regulation in Children in Bangladesh","status":"UNKNOWN","sponsor":"Boston Children's Hospital","startDate":"2022-02-07","conditions":"Executive Function Disorder, Emotional Regulation, Malnutrition, Child","enrollment":280},{"nctId":"NCT04698070","phase":"NA","title":"Optimizing Acute Malnutrition Management in Children Aged 6 to 59 Months in Niger (OptIMA Niger)","status":"COMPLETED","sponsor":"Alliance for International Medical Action","startDate":"2021-03-22","conditions":"Acute Malnutrition in Infancy (Disorder)","enrollment":2304},{"nctId":"NCT05322538","phase":"NA","title":"Menier's Disease - Bone Density Study","status":"NOT_YET_RECRUITING","sponsor":"HaEmek Medical Center, Israel","startDate":"2022-10-01","conditions":"Meniere Disease, Osteoporosis, Osteopenia","enrollment":60},{"nctId":"NCT05005065","phase":"PHASE1","title":"Evaluation of the Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 and IN-A001 in Healthy Caucasians","status":"COMPLETED","sponsor":"HK inno.N Corporation","startDate":"2021-09-06","conditions":"Healthy","enrollment":20},{"nctId":"NCT05353712","phase":"NA","title":"Effect of Consuming Products Containing Rare Sugars Alongside Sucrose on Glycaemic Response in Healthy Adults","status":"UNKNOWN","sponsor":"University of Nottingham","startDate":"2022-05","conditions":"Glycaemic Response in Healthy Participants","enrollment":20},{"nctId":"NCT03485404","phase":"NA","title":"Preoperative Vitamin B12 and Folic Acid on POCD in Elderly Non-cardiac Surgical Patients","status":"TERMINATED","sponsor":"Xijing Hospital","startDate":"2019-01-10","conditions":"Post Operative Cognitive Dysfunction","enrollment":40},{"nctId":"NCT00834184","phase":"PHASE1","title":"Safety and PK of Nikkomycin Z in Healthy Subjects","status":"COMPLETED","sponsor":"University of Arizona","startDate":"2008-10","conditions":"Healthy","enrollment":32},{"nctId":"NCT04395768","phase":"PHASE2","title":"International ALLIANCE Study of Therapies to Prevent Progression of COVID-19","status":"UNKNOWN","sponsor":"National Institute of Integrative Medicine, Australia","startDate":"2020-09-09","conditions":"COVID19","enrollment":200},{"nctId":"NCT00720109","phase":"PHASE2, PHASE3","title":"Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2008-07-14","conditions":"Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1","enrollment":63},{"nctId":"NCT02168660","phase":"PHASE2","title":"Correction of Vitamin D Levels and Its Effect on Insulin Resistance and Weight Gain in Obese Youth","status":"COMPLETED","sponsor":"Perrin C White, MD","startDate":"2011-03","conditions":"Obesity, Insulin Resistance, Vitamin D Deficiency","enrollment":109},{"nctId":"NCT03331042","phase":"PHASE3","title":"SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.","status":"COMPLETED","sponsor":"Sequential Medicine Ltd","startDate":"2017-10-09","conditions":"Transient Insomnia","enrollment":85},{"nctId":"NCT01590732","phase":"PHASE1","title":"Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2012-10-29","conditions":"Mycosis Fungoides, Recurrent Anaplastic Large Cell Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma","enrollment":22},{"nctId":"NCT02784275","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 Diabetes","status":"COMPLETED","sponsor":"NovMetaPharma Co., Ltd.","startDate":"2016-06-09","conditions":"Diabetes Mellitus Type 2 in Obese","enrollment":64},{"nctId":"NCT03365310","phase":"NA","title":"Management of Frailty in Older Adults With Turmeric and Tulsi Supplements","status":"UNKNOWN","sponsor":"Composite Interceptive Med Science","startDate":"2018-07-01","conditions":"Frail Elderly Syndrome","enrollment":50},{"nctId":"NCT00419692","phase":"PHASE1","title":"Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-08-24","conditions":"Restless Legs Syndrome","enrollment":32},{"nctId":"NCT01055314","phase":"PHASE2","title":"Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2010-01","conditions":"Adult Rhabdomyosarcoma, Childhood Alveolar Rhabdomyosarcoma, Childhood Embryonal Rhabdomyosarcoma","enrollment":175},{"nctId":"NCT02703896","phase":"PHASE4","title":"Prophylaxis for Aspiration of Gastric Contents.","status":"COMPLETED","sponsor":"King Saud University","startDate":"2012-01","conditions":"Pulmonary Aspiration of Gastric Contents","enrollment":1920},{"nctId":"NCT00850746","phase":"PHASE1","title":"A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Adults","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2009-02","conditions":"Functional Dyspepsia","enrollment":80},{"nctId":"NCT00495326","phase":"PHASE2, PHASE3","title":"Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)","status":"COMPLETED","sponsor":"French National Agency for Research on AIDS and Viral Hepatitis","startDate":"2007-12","conditions":"Tuberculosis, Aids, Hiv Infections","enrollment":570},{"nctId":"NCT00663013","phase":"NA","title":"Virtual Reality for Burn Wound Care Pain Control","status":"UNKNOWN","sponsor":"Weill Medical College of Cornell University","startDate":"2007-10","conditions":"Pain, Anxiety","enrollment":12},{"nctId":"NCT00388609","phase":"PHASE2","title":"Multiple-dose Study to Evaluate the Efficacy, Safety and Pharmacokinetics of BMS-646256 in Obese Subjects","status":"TERMINATED","sponsor":"Bristol-Myers Squibb","startDate":"2006-11","conditions":"Obesity","enrollment":705}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"MALIGNANT MELANOMA"}],"_approvalHistory":[],"publicationCount":934,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"D+Z","genericName":"D+Z","companyName":"Sequential Medicine Ltd","companyId":"sequential-medicine-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"D+Z is a fixed-dose combination of daclatasvir and sofosbuvir that inhibits hepatitis C virus NS5A and NS5B proteins to block viral replication. Used for Chronic hepatitis C virus infection (genotype-independent).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}